Articles

What's up with XPEV stock? Here's why shares of Xpeng are taking off today on a rather mixed day in the overall markets. More

Allarity Therapeutics became the toast of Wall Street Wednesday with positive early clinical data, though ALLR stock remains risky. More

Digital World Acquisition may be about to finally settle its ongoing SEC investigation. Here's why it won't save DWAC stock. More

The question of why are stocks down today is one that many are asking, as this bull market rally takes a breather. More

With these companies fueling sales and earnings with medical innovations and breakthroughs, they may be the best biotech stocks to pick up. More

Mullen CEO David Michery recently disclosed guidance for the remainder of the year and for 2024. Here's what it means for MULN stock. More

So many investors are looking for a recession, but what if one never comes? Let's look at stocks for economic boom instead. More

Subscriber Sign in